Statistical methods in endocrinology & metabolism trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
ANCOVA
Multiple imputation / missing data
Non-inferiority trial design
Logistic regression
Odds ratio
Mixed-effects model
MMRM (mixed model for repeated measures)
Cochran-Mantel-Haenszel test
All endocrinology & metabolism trials
1,009 results
- TWO2DFUIndependent statistical analysis of Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- UKPDSIndependent statistical analysis and educational interpretation of UKPDS (NCT01099865), evaluating high-sensitivity C-reactive protein and UKPDS Risk Score in type 2 diabetes.
- VA CARDSIndependent statistical analysis of Coronary Artery Revascularization in Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00326196).
- VA NEPHRON-DComplete statistical analysis of VA NEPHRON-D, a randomized phase 3 trial evaluating combination ARB and ACEI therapy versus ARB monotherapy in patients with diabetic nephropathy, including time-to-event endpoints, hazard ratios, confidence intervals,…
- VC01-103Independent statistical analysis of A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VERTIS CVIndependent statistical analysis of VERTIS CV (NCT01986881): a stratified Cox non-inferiority analysis of ertugliflozin versus placebo for MACE with a 1.3 hazard-ratio margin, cLDA analyses of A1C change in glycemic sub-studies, secondary…
- VICTORION-2PAn independent statistical analysis of VICTORION-2P, a randomized phase 3 trial evaluating inclisiran for prevention of cardiovascular events in participants with established atherosclerotic cardiovascular disease.
- WalkITIndependent statistical analysis of A Walking Intervention Through Text Messaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02053259).
- WU197Independent statistical analysis of Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00656851).